CTSH
60
-3
LMT
30
-2
STZ
52
-6
SRE
63
2
SHW
62
-6
XYL
35
-2
NVDA
52
-5
SJM
9
-5
DVN
14
-6
LRCX
37
-9
TXN
43
-5
AXP
67
-2
SO
57
6
FMC
23
-3
HIG
66
2
WAT
48
-11
SYY
49
9
XOM
42
-6
ROP
53
-9
F
56
-3
CTSH
60
-3
LMT
30
-2
STZ
52
-6
SRE
63
2
SHW
62
-6
XYL
35
-2
NVDA
52
-5
SJM
9
-5
DVN
14
-6
LRCX
37
-9
TXN
43
-5
AXP
67
-2
SO
57
6
FMC
23
-3
HIG
66
2
WAT
48
-11
SYY
49
9
XOM
42
-6
ROP
53
-9
F
56
-3
Financhill
Back

Matthews Emerging Markets Ex Chn Act ETF Vs. Neurogene Industry Stock Comparison

Sell
32

MEMX
Matthews Emerging Markets Ex Chn Act ETF

Last Price:
29.22
Seasonality Move:
8.21%
Sell
1

NGNE
Neurogene

Last Price:
34.67
Seasonality Move:
50.43%
Sell
32
Matthews Emerging Markets Ex Chn Act ETF (MEMX) is a Sell

Is Matthews Emerging Markets Ex Chn Act ETF a Buy, Sell or Hold?

  • The current Matthews Emerging Markets Ex Chn Act ETF [MEMX] share price is $29.27. The Score for MEMX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • MEMX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

MEMX Stock Price Chart

What is Matthews Emerging Markets Ex Chn Act ETF's stock price today?

  • The Matthews Emerging Markets Ex Chn Act ETF share price today is $29.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MEMX is experiencing slight buying pressure.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $34.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

MEMX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 28.6 Sell
Chaikin Money Flow: 2391 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.87 - 30.77) Sell
Bollinger Bands (100): (29.76 - 30.98) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 35.74 Sell
Chaikin Money Flow: -452975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.4 - 61.5) Sell
Bollinger Bands (100): (34.32 - 50.52) Sell

MEMX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.85 Sell
20-day SMA: 30.22 Sell
50-day SMA: 30.5 Sell
200-day SMA: 29.64 Sell
8-day EMA: 29.73 Sell
20-day EMA: 30.08 Sell
50-day EMA: 30.3 Sell
200-day EMA: 29.51 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Sell
20-day SMA: 51.47 Sell
50-day SMA: 46.76 Sell
200-day SMA: 38.99 Sell
8-day EMA: 47.13 Sell
20-day EMA: 50.2 Sell
50-day EMA: 47.47 Sell
200-day EMA: 38.44 Sell

Matthews Emerging Markets Ex Chn Act ETF Earnings Growth & MEMX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Matthews Emerging Markets Ex Chn Act ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):